Ebselen protects brain, skin, lung and blood cells from mechlorethamine toxicity

Toxicology and Industrial Health

Volumn 23, Issue 4, 2007, Pages 209-221

  Hardej, Diane ^a   Billack, Blase ^a  

^a ST JOHN'S UNIVERSITY   (United States)

Author keywords

ebselen; in vitro toxicology; nitrogen mustard

Indexed keywords

CHLORMETHINE; EBSELEN;

ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; NEUROPROTECTION; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; SKIN PROTECTION;

ANIMALS; ASTROCYTES; AZOLES; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; CHEMICAL WARFARE AGENTS; CYTOPROTECTION; DRUG EVALUATION; EPITHELIAL CELLS; HIPPOCAMPUS; HUMANS; MECHLORETHAMINE; MICROSCOPY; NEUROPROTECTIVE AGENTS; ORGANOSELENIUM COMPOUNDS; PLEURA; RATS; RATS, SPRAGUE-DAWLEY; T-LYMPHOCYTES;

BRASSICACEAE; RATTUS;

EID: 36949014095     PISSN: 07482337     EISSN: None     Source Type: Journal    
DOI: 10.1177/0748233707083541     Document Type: Article

References (34)

1. Agency for Toxic Substances and Disease Registry (ATSDR) 2007. Toxicological profile for Sulfur Mustards Atlanta, GA; US Department of Health and Human Services, Public Health Service.
2. Brennan, R.J., Waeckerle, J.F., Sharp, T.W. et al. 1999: Chemical warfare agents: emergency medical and emergency public health issues. Annals of Emergency Medicine 34, 191—204.
3. Burgess, J.L., Kirk, M., Borron, S.W. et al. 1999: Emergency department hazardous materials protocol for contaminated patients. Annals of Emergency Medicine 34, 205—12.
4. Chabner, B.A., Allegra, C.J., Curt, G.A. et al. 1995: Antineoplastic agents. In Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W. and Gilman, A.G., editors. Goodman and Gilman's the pharmacological basis of therapeutics, ninth edition, New York, McGraw Hill, 1233—87.
5. Cotgreave, I.A., Sandy, M.S., Berggren, M. et al. 1987: N-acetylcysteine and glutathione- dependent protective effect pf PZ51 (ebselen) against diquat- induced cytotoxicity in isolated hepatocytes. Biochemical Pharmacology 36, 2899—904.
6. Dacre, J.C. and Goldman, M. 1996: Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacology Review 48, 289—326.
7. Decker, E.A., Warner, K., Richards, M.P. et al. 2005: Measuring antioxidant effectiveness in food. Journal of Agricultural and Food Chemistry 53, 4303—10.
8. Dringen, R. 2000: Metabolism and function of glutathione in the brain. Progress in Neurobiology 62, 649—71.
9. Engman, L., Cotgreave, I., Angulo, M. et al. 1997: Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents. Anticancer Research 17, 4599—605.
10. Greenfield, R.A., Brown, B.R., Hutchins, J.B. et al. 2002: Microbiological, biological, and chemical weapons of warfare and terrorism. American Journal of Medical Science 323, 326—40.
11. Gross, C.L., Innace, J.K., Hovatter, R.C. et al. 1993: Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biology and Toxicology 9, 259—67.
12. Haenen, G.R.M.M., De Rooji, B.M., Vermeulen, N.P.E. et al. 1990: Mechanism of the reaction of ebselen with endogenous thiols: dihydrolipoate is a better cofactor than glutathione in the peroxidase activity of ebselen. Molecular Pharmacology 37, 412—22.
13. Hardej, D., and Trombetta, L.D., 2002: The effects of ebselen on cisplatin and diethyldithiocarbamate (DDC) cytotoxicity in rat hippocampal astrocytes. Toxicology Letters 131, 215—226.
14. Holl, V., Coelho, D., Silbernagel, L. et al. 2000: Prevention of nitrogen mustard-induced apoptosis in normal and transformed lymphocytes by ebselen. Biochemical Pharmacology. 60, 1565—77.
15. International Agency for Research on Cancer (IARC) 1975: Mustard gas: Monograph for the Evaluation of Carcinogenic Risk and Chemical Management 9, 181—92.
16. Kromidas, L., Trombetta, L.D. and Jamall, I.S. 1990: The protective effects of glutathione against methylmercury cytotoxicity. Toxicology Letters 51, 67—80.
17. Kuhl, P., Borbe, H.O., Fischer, H. et al. 1986: Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S, 12R-6-trans-isomer. Prostaglandins 31, 1029—48.
18. Langford, A.M., Hobbs, M.J., Upshall, D.G. et al. 1996: The effect of sulphur mustard on glutathione levels in rat lung slices and the influence of treatment with arylthiols and cysteine esters. Human Experimental Toxicology 15, 619—24.
19. Ludwin, S.K., Kosek, J.C. and Eng, L.F. 1976: The topographical distribution of S-100 and GFA proteins in the adult rabbit brain: an immunohistochemical study using horseradish peroxidase-labelled antibodies. Journal of Comparative Neurology 165, 197—207.
20. Lunel-Orsini, C., Buttin, G. and Saint Vincent, B.R. 1995: A glutathione depletion selectively imposed on mu glutathione S-transferase overproducing cells increases nitrogen mustard toxicity. Biochemical Pharmacology 49, 329—38.
21. McManus, M.F. and Trombetta, L.D. 1995: The effects of diethyldithiocarbamate (DDC) on the astrocytic cytoskeleton. Scanning Microscopy 9, 257—70.
22. Mossmann, T. 1983: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 55—63.
23. Müller, A., Cadenas, E., Graf, P. and Sies, H. 1984: A novel biologically active seleno-organic compound — I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ 51 (Ebselen). Biochemical Pharmacology 33, 3235—39.
24. Müller, A., Gabriel, H. and Sies, H. 1985: Protective glutathione-dependent effect of PZ51 (ebselen) against ADP-Fe induced lipid peroxidation in isolated hepatocytes. Biochemical Pharmacology 34, 1185—89.
25. Naghii, M.R. 2002: Sulfur mustard intoxication, oxidative stress and antioxidants. Military Medicine 167, 573—75.
26. Saladi, R.N., Smith, E. and Persaud, A.N. 2006: Mustard: a potential agent of chemical warfare and terrorism. Clinical and Experimental Dermatology 31, 1—5.
27. Schewe, T. 1995: Molecular actions of ebselen-an anti-inflammatory antioxidant. General Pharmacology 26, 1153—69.
28. Scott, R.B. 1970: Cancer chemotherapy — the first twenty-five years. British Medical Journal 4, 259—65.
29. Sies, H. 1993: Ebselen, a selenoorganic compound as glutathione peroxidase mimic. Free Radicals in Biology and Medicine 14, 313—23.
30. Smith, K.J., Hurst, C.G., Moeller, R.B. et al. 1995: Sulfur mustard: its continuing threat as a chemical warfare agent, the cutaneous lesions induced, progress in understanding its mechanism of action, its long-term health effects and new developments for protection and therapy. Journal of the American Academy of Dermatology 32, 765—76.
31. Sourdeval, M., Lemave, C., Deniaud, A., et al. 2006: Inhibition of caspase-dependent mitochandrial permeability transition protects airway epithelial cells against mustard-induced apoptosis, Apoptosis, 11, 1545—1559.
32. Walther, M., Holzhutter, H.G., Kuban, R.J. et al. 1999: The inhibition of mammalian 15-lipoxygenases by the anti-inflammatory drug ebselen: dual-type mechanism involving covalent linkage and alteration of the iron ligand sphere. Molecular Pharmacology 56, 196—203.
33. Wendel, A., Kuesters, S. and Tiegs, G. 1997: Ebselen- an in vivo immune response modifier. Biomedical and Environmental Science 10, 253—59.
34. Yamaguchi, T., Sano, K., Takakura, K. et al. 1998: Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke 29, 12—17.